PQ 1215
1215. Deputy Pádraig O'Sullivan asked the Minister for Health if she will outline what steps her Department is taking to address the fact that brexpiprazole and lurasidone, two antipsychotic medicines now recommended as first-line treatment options for females with first-episode psychosis in the first international clinical guideline of its kind published in March 2026, are currently licensed in Ireland but not reimbursable under community drugs schemes; and if she will make a statement on the matter. [35183/26]
Introduced
12 May 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
12 May 2026
Summary
1215. Deputy Pádraig O'Sullivan asked the Minister for Health if she will outline what steps her Department is taking to address the fact that brexpiprazole and lurasidone, two antipsychotic medicines now recommended as first-line treatment options for females with first-episode psychosis in the first international clinical guideline of its kind published in March 2026, are currently licensed in Ireland but not reimbursable under community drugs schemes; and if she will make a statement on the matter. [35183/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 12 May 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-05-12/1215/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-05-12/pq_1215